Kersten Gideon, Hirschberg Hoang
Netherlands Vaccine Institute, Research and Development Department, PO Box 457, 3720 Al Bilthoven, The Netherlands.
Expert Opin Drug Deliv. 2007 Sep;4(5):459-74. doi: 10.1517/17425247.4.5.459.
The need for minimally invasive delivery methods is urgent. As the number of registered vaccines increases, so does the number of injections. The use of sharps can be unsafe and needle immunisation is less suitable for mass immunisations during emergencies such as pandemics or bioterrorist attacks. The approach of combining vaccines has limitations due to high development costs, risk of pharmaceutical or immunological interference and economic risks. Advancements in the development of alternatives to injection with syringes and needles are discussed in this paper, and include: mucosal vaccination, injection without needles and vaccine delivery via the skin.
对微创给药方法的需求迫在眉睫。随着注册疫苗数量的增加,注射次数也在增加。锐器的使用可能不安全,而且在大流行或生物恐怖袭击等紧急情况下,针头免疫不太适合大规模免疫。联合疫苗的方法存在局限性,原因包括开发成本高、存在药物或免疫干扰风险以及经济风险。本文讨论了注射器和针头注射替代方法的开发进展,包括:粘膜疫苗接种、无针注射和经皮疫苗递送。